Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Anti-HCV Next

K-Number: K252424 · 2026-04-28

Decision Date2026-04-28
Product CodeMZO
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

Anti-HCV Next is a medical device manufactured by Abbott Laboratories. It received FDA 510(k) clearance on 2026-04-28 under approval number K252424. The device is classified under product code MZO. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Anti-HCV Next?

Anti-HCV Next is a medical device that received FDA 510(k) clearance on 2026-04-28. It is manufactured by Abbott Laboratories. The 510(k) number is K252424.

When was Anti-HCV Next approved by the FDA?

Anti-HCV Next received FDA 510(k) clearance on 2026-04-28, under approval number K252424.

What company makes Anti-HCV Next?

Anti-HCV Next is manufactured by Abbott Laboratories.

What is the FDA product code for Anti-HCV Next?

The FDA product code for Anti-HCV Next is MZO.

Other Devices by Abbott Laboratories

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.